Home > Insider Trading > Filing (0001140361-20-023079)

Filing Details

Accession Number:: 0001140361-20-023079
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-15 21:15:54
Reporting Period:: 2020-10-13

Accepted Time:: 2020-10-15 21:15:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
931148	Graftech International Ltd	EAF	Electrical Industrial Apparatus (3620)	272496053

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1001085	Brookfield Asset Management Inc.	Brookfield Place, 181 Bay Street Suite 300 Po Box 762 New York NY 10281-1023	No	No	No	No
1642338	L.p. Holdings Graftech Iv Bcp	C/O Brookfield Asset Management Inc. 181 Bay St, Ste. 300 Toronto A6 M5J2T3	No	No	No	No
1654795	L.p. Partners Business Brookfield	73 Front Street, 5Th Floor Hamilton D0 HM 12	No	No	No	No
1685113	Brookfield Private Equity Inc.	Brookfield Place 181 Bay Street, Suite 300 Toronto A6 M5J2T3	No	No	No	No
1685157	Brookfield Private Equity Group Holdings Lp	Brookfield Place 181 Bay Street, Suite 300 Toronto A6 M5J2T3	No	No	No	No
1685158	Ltd. Partners Capital Brookfield	C/O Brookfield Asset Management Inc. 181 Bay St, Ste. 300 Toronto A6 M5J2T3	No	No	No	No
1685160	Ltd Gp Bcp	C/O Brookfield Asset Management Inc. 181 Bay St, Ste. 300 Toronto A6 M5J2T3	No	No	No	No
1703248	Brookfield Private Equity Holdings Llc	Brookfield Place 200 Vesey Street New York NY 10281-1023	No	No	No	No
1738295	(Non-Cdn) Iv Bpe	C/O Brookfield Asset Management Inc. 181 Bay St, Ste. 300 Toronto A6 M5J2T3	No	No	No	No
1768973	Brookfield Us Inc.	Brookfield Place 200 Vesey Street New York NY 10281-1023	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-10-13	34,393	$7.26	171,944,427	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-13	36,223	$7.26	171,908,204	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-13	64,384	$7.26	171,843,820	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-14	35,438	$7.40	171,808,382	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-14	37,324	$7.40	171,771,058	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-14	66,341	$7.40	171,704,717	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-15	34,902	$7.24	171,669,815	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-15	36,760	$7.24	171,633,055	No	4	S	Indirect	See Explanation of Responses
Common Stock	Disposition	2020-10-15	65,338	$7.24	171,567,717	No	4	S	Indirect	See Explanation of Responses

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses
No	4	S	Indirect	See Explanation of Responses

Footnotes

The sales reported in this Form 4 (the "Sales") were effected pursuant to a Rule 10b5-1 trading plan adopted by BPE IV (Non-Cdn) GP LP, Brookfield BBP (Canada) L.P. and Brookfield BBP Canada Holdings Inc.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of BPE IV (Non-Cdn) GP LP in multiple transactions at prices ranging from $7.18 to $7.38 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of Brookfield BBP (Canada) L.P. in multiple transactions at prices ranging from $7.18 to $7.38 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of Brookfield BBP Canada Holdings Inc. in multiple transactions at prices ranging from $7.18 to $7.38 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of BPE IV (Non-Cdn) GP LP in multiple transactions at prices ranging from $7.11 to $7.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of Brookfield BBP (Canada) L.P. in multiple transactions at prices ranging from $7.11 to $7.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of Brookfield BBP Canada Holdings Inc. in multiple transactions at prices ranging from $7.11 to $7.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of BPE IV (Non-Cdn) GP LP in multiple transactions at prices ranging from $7.00 to $7.41 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of Brookfield BBP (Canada) L.P. in multiple transactions at prices ranging from $7.00 to $7.41 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold on behalf of Brookfield BBP Canada Holdings Inc. in multiple transactions at prices ranging from $7.00 to $7.41 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Following the Sales, consists of (i) 149,216,541 shares of Common Stock held directly by BCP IV; (ii) 5,694,065 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (iii) 5,997,150 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iv) 10,659,434 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; and (v) 527 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.
BAM, by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares.
BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BAM, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BAM, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP.
Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BAM, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BAM, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P.
Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BAM, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. BAM, by virtue of its relationship with Brookfield Private Funds Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield Private Funds Holdings Inc.
Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.